CR in rodents reduces IGF-1/insulin–phosphatidylinositol-3 kinase-Akt-mammalian target of rapamycin complex 1 signalling, which has been shown to be correlated with significant tumor growth delay61, 62. The gene discussed is AKT1; the disease is neoplasm.